01-03-2002 | Basic/Clinical Science
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis
Published in: Journal of Cutaneous Medicine and Surgery | Issue 2/2002
Login to get access